Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces its pioneering efforts to develop ...

Smith & Nephew (NYSE:SNN) quickly edged higher by ~1% after a report that it's considering a break-up amid activist pressure.

Smith+Nephew (NYSE: SNN) announced today that it aims to develop technology in a new field of arthroscopic surgical ...

Smith+Nephew announces its efforts to develop technology in the field of Spatial Surgery – a new frontier in arthroscopic surgical innovation.

Despite ongoing pressures in China, revenue and trading profit at the FTSE 100 firm rose 5.3% and 8.2% respectively in 2024.

Smith & Nephew Plc Chief Executive Officer Deepak Nath said a transformation plan unveiled two years ago will clearly start ...

The medical-technology company was boosted by its sports medicine segment and an improved trading margin.

Medical products maker Smith+Nephew's wound business will take a hit from U.S. tariffs on imports from China, as the British company has "significant" manufacturing in the Asian country for that ...

Canaccord Genuity Group reiterated their hold rating on shares of Smith & Nephew (NYSE:SNN – Free Report) in a research report report published on Wednesday morning,Benzinga reports. Canaccord Genuity ...

Smith+Nephew reported annual sales and profit broadly in line with expectations on Tuesday, as newer products and a recovery in the U.S., helped the medical products maker offset the impact of ...

The chief executive of medical device maker Smith & Nephew has rejected shareholder calls to break up the business, as the ...

The medical technology giant, which is listed on the FTSE 100, has been in the midst of a turnaround effort, and recently ...